We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+3.24%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.34B
AUM Growth
-$48.8M
(-3.5%)
Cap. Flow
-$46.2M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
22.05%
Holding
140
New
8
Increased
36
Reduced
80
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Heron Therapeutics
HRTX
|
+$13.3M |
| 2 |
HOME
At Home Group Inc.
HOME
|
+$11M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$9.49M |
| 4 |
Verra Mobility
VRRM
|
+$8.01M |
| 5 |
Yeti Holdings
YETI
|
+$7.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$17.2M |
| 2 |
EFII
Electronics for Imaging
EFII
|
+$16.9M |
| 3 |
ADSW
Advanced Disposal Services Inc
ADSW
|
+$12.8M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.6M |
| 5 |
QTNA
Quantenna Communications, Inc. Common Stock
QTNA
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.27% |
| 2 | Technology | 15.92% |
| 3 | Industrials | 15.31% |
| 4 | Communication Services | 11.67% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
1
DELISTED
Interxion Holding N.V.
INXN
| $47.7M | 3.56% |
626,418
-30,531
| -5% | -$2.18M |
|
|
QUOT
2
DELISTED
Quotient Technology Inc
QUOT
| $44.6M | 3.33% |
4,152,577
-177,038
| -4% | -$1.8M |
|
3
Cerus
CERS
$431M
| $38.4M | 2.87% |
6,840,991
+1,100,700
| +19% | +$6.08M |
|
|
SNCR
4
DELISTED
Synchronoss Technologies
SNCR
| $33.9M | 2.54% |
476,846
+117,518
| +33% | +$6.63M |
|
5
Ligand Pharmaceuticals
LGND
$5.76B
| $27.5M | 2.06% |
386,499
+50,153
| +15% | +$3.69M |
|
6
Pacira BioSciences
PCRX
$1.04B
| $21.7M | 1.63% |
500,069
-64,507
| -11% | -$2.74M |
|
7
MaxLinear
MXL
$6.06B
| $21.1M | 1.57% |
898,845
-192,275
| -18% | -$4.68M |
|
|
WAGE
8
DELISTED
WageWorks, Inc.
WAGE
| $21M | 1.57% |
412,939
-153,752
| -27% | -$7.27M |
|
9
MasTec
MTZ
$20.8B
| $19.9M | 1.48% |
385,205
-18,641
| -5% | -$921K |
|
|
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
| $19.2M | 1.44% |
644,711
+39,970
| +7% | +$1.22M |
|
11
Healthcare Services Group
HCSG
$1.6B
| $19M | 1.42% |
627,333
+4,380
| +0.7% | +$145K |
|
12
OneSpan
OSPN
$574M
| $19M | 1.42% |
1,337,933
+177,905
| +15% | +$2.83M |
|
|
IVC
13
DELISTED
Invacare Corporation
IVC
| $18.4M | 1.38% |
3,549,452
+371,945
| +12% | +$2.42M |
|
|
NXGN
14
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $18M | 1.35% |
906,641
+511
| +0.1% | +$9.54K |
|
15
Iridium Communications
IRDM
$5.02B
| $17.8M | 1.33% |
764,297
-78,566
| -9% | -$1.96M |
|
16
Evolent Health
EVH
$348M
| $17.2M | 1.29% |
2,168,810
+335,917
| +18% | +$3.98M |
|
|
IPHI
17
DELISTED
INPHI CORPORATION
IPHI
| $17.1M | 1.28% |
341,026
-228,991
| -40% | -$10.7M |
|
|
CVSA
18
Covista Inc
CVSA
$4.25B
| $17.1M | 1.28% |
379,121
-13,516
| -3% | -$620K |
|
|
EXAS
19
DELISTED
Exact Sciences
EXAS
| $16.1M | 1.2% |
135,982
-4,255
| -3% | -$429K |
|
20
Churchill Downs
CHDN
$5.88B
| $15.7M | 1.17% |
272,196
-62,880
| -19% | -$3.16M |
|
|
NGHC
21
DELISTED
National General Holdings Corp
NGHC
| $15.6M | 1.16% |
677,880
-26,604
| -4% | -$635K |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| $15.3M | 1.14% |
1,026,975
+525,251
| +105% | +$9.49M |
|
23
Essent Group
ESNT
$6.08B
| $15.1M | 1.13% |
322,222
-14,037
| -4% | -$661K |
|
24
Gogo Inc
GOGO
$565M
| $14.5M | 1.08% |
3,632,984
-130,475
| -3% | -$633K |
|
|
MTOR
25
DELISTED
MERITOR, Inc.
MTOR
| $14.3M | 1.07% |
591,712
+50,068
| +9% | +$1.13M |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Elk Creek Partners held 140 positions worth $1.34B, down 3.5% from $1.39B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Elk Creek Partners withdrew a net $46.2M in Q2 2019, closing 16 positions and reducing 80 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $17.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
Against the trend, Elk Creek Partners opened a new position in Heron Therapeutics worth $12.4M.
- Elk Creek Partners's largest Q2 2019 buy was Heron Therapeutics: 668,240 shares worth $12.4M.
- Elk Creek Partners added most to Clovis Oncology, Inc. in Q2 2019, an estimated $9.49M increase.
- Elk Creek Partners's biggest Q2 2019 reduction was Electronics for Imaging, cutting an estimated $16.9M.
- Elk Creek Partners fully exited R1 RCM Inc. Common Stock in Q2 2019, selling an estimated $17.2M.
- Elk Creek Partners's ten largest holdings make up 22% of its $1.34B portfolio in Q2 2019.
- Elk Creek Partners opened 8 new positions and closed 16 in Q2 2019.
- Elk Creek Partners's portfolio value fell 3.5% quarter-over-quarter to $1.34B.
Based on Elk Creek Partners's 13F filing for Q2 2019, filed 9 Aug 2019.